Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) shareholders are no doubt pleased to see that the share price has bounced 45% in the last month, although it is still struggling to make up recently lost ground. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 48% in the last twelve months.
Even after such a large jump in price, it would still be understandable if you think Shanghai Xuerong BiotechnologyLtd is a stock with good investment prospects with a price-to-sales ratios (or “P/S”) of 0.8x, considering almost half the companies in China’s Food industry have P/S ratios above 1.4x. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the reduced P/S.
View our latest analysis for Shanghai Xuerong BiotechnologyLtd
